Rachel Waldron
Rakoczy Molino Mazzochi Siwik LLP
Log In

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Experience10 yrs
Elite Ratings
DCT,
PTAB,
CAFC
Practice Areas
Communications (150 cases)
Biotech (140 cases)
Design (130 cases)
Law Firms
Rakoczy Molino Mazzochi Siwik LLP (Current)
john.doe@email.com
rmmslegal.com

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
A

Cases

Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Case #
Court
Caption
Filed
Represent
1:00-CV-00001
D. DE
In re: Xarelto (Rivaroxaban) ('310) Patent Litigation12/10/21
Patent Owner
: Samsung Electronics Co Ltd
1:00-CV-00002
D. DE
Astellas Pharma Inc v. Sandoz Inc11/24/20
Challenger (L)
: Apple Inc
1:00-CV-00003
D. DE
Pfizer Inc v. Glenmark Pharma Ltd06/26/19
Patent Owner
: Google LLC
1:00-CV-00004
D. NJ
Taro Pharma USA Inc v. Glenmark Pharma Ltd08/08/18
Challenger (W)
: Microsoft Corp
1:00-CV-00005
D. NJ
Adamas Pharma LLC v. Sandoz Inc05/10/18
Patent Owner (L)
: LG Electronics Inc
1:00-CV-00006
D. NJ
Impax Laboratories Inc v. Sandoz Inc03/31/17
Challenger
: Facebook Inc
1:00-CV-00007
D. DE
In re: Copaxone 775 Patent Litigation12/19/16
Patent Owner (W)
: Intel Corp
1:00-CV-00008
D. DE
Johns Hopkins University v. Alcon Laboratories Inc06/23/15
Challenger (W)
: Uniloc USA Inc
1:00-CV-00009
D. DE
In Re Copaxone 40 MG Consolidated Cases09/10/14
Patent Owner
: Sony Corp
1:00-CV-00010
D. NJ
Astrazeneca Pharma LP v. Sagent Pharma Inc06/03/14
Challenger (L)
: Cisco Systems Inc

Ratings Trends

Practice Areas